收稿日期: 2024-11-05
录用日期: 2025-03-29
网络出版日期: 2025-09-09
A case report of Waardenburg syndrome with primary amenorrhea and short stature, and a review of literature
Received date: 2024-11-05
Accepted date: 2025-03-29
Online published: 2025-09-09
本文报道1例17岁女性患者,因第二性征未发育和原发性闭经就诊。患者临床表现为听力下降、虹膜呈蓝色、双内眦增宽,并伴有身材矮小、双侧肘外翻及盾状胸。实验室检查提示低促性腺激素性性腺功能减退,同时合并不完全性生长激素缺乏。彩超检查显示始基子宫。全外显子组测序发现其SOX10基因存在c.1029dup (p.Thr344Hisfs*58)突变,确诊为瓦登伯格综合征(Waardenburg syndrome, WS)。Sanger测序验证该突变为新发突变,目前公共数据库中尚未收录该突变。家系调查结果显示,患者父母的外周血样本中未检出该突变。本报道突变丰富了WS疾病基因突变谱和临床相关数据。对于存在不明原因听力障碍、色素沉着异常伴生长发育迟缓的儿童,应考虑SOX10基因突变可能,尽早行基因检测以明确诊断。
关键词: SOX10; 瓦登伯格综合征; 色素沉着异常; 低促性腺激素性性腺功能减退症; 听力丧失
姚昕 , 李梦洁 , 叶山东 , 郑茂 . 瓦登伯格综合征合并原发性闭经和身材矮小一例报道及文献复习[J]. 诊断学理论与实践, 2025 , 24(04) : 455 -458 . DOI: 10.16150/j.1671-2870.2025.04.013
This article reports a case of a 17-year-old female patient who presented with absent secondary sexual characteristics and primary amenorrhea. The patient's clinical manifestations included hearing loss, blue irides, and telecanthus, accompanied by short stature, bilateral cubitus valgus, and shield-shaped chest. Laboratory tests indicated hypogonadotropic hypogonadism with partial growth hormone deficiency, and ultrasound revealed a rudimentary uterus. Whole-exome sequencing identified a c.1029dup (p.Thr344Hisfs*58) mutation in the SOX10 gene, confirming the diagnosis of Waardenburg syndrome (WS). Sanger sequencing confirmed that this was a de novo mutation, which has not been reported in public databases. Family investigation showed that the mutation was not detected in peripheral blood samples from the patient's parents. This mutation expands the genetic mutation spectrum and clinical data of WS. In cases of unexplained hearing impairment, abnormal pigmentation, and growth retardation in children, SOX10 gene mutation should be conside-red, and genetic testing should be performed early to establish a diagnosis.
| [1] | HUANG S, SONG J, HE C, et al. Genetic insights, di-sease mechanisms,and biological therapeutics for Waardenburg syndrome[J]. Gene Ther, 2022, 29 (9) :479-497. |
| [2] | ROJAS R A, KUTATELADZE A A, PLUMMER L, et al. Phenotypic continuum between Waardenburg syndrome and idiopathic hypogonadotropic hypogonadism in humans with SOX10 variants[J]. Genet Med, 2021; 23(4):629-636. |
| [3] | LI Y, CHEN Y, SUN Y, et al. Waardenburg syndrome type 2 with a de novo variant of the SOX10gene: a case report[J]. BMC Med Genomics, 2024, 17(1):104-111. |
| [4] | 任洁, 闫旭红, 张梦瑶, 等. 瓦登伯格综合征伴性腺功能减退症1例并文献复习[J]. 中国临床案例成果数据库, 2023, 05(01):E02338-E02338. |
| REN J, YAN X H, ZHANG M Y, et al. Vardenberg syndrome with hypogonadism: a case report and literature review[J]. China Clin Case Database, 2023, 5(1):E02338-E02338. | |
| [5] | WANG S Q, CHEN Y, LUO K H, et al. Diagnosis and genetic analysis of a case of Waardenburg syndrome type 2 with hypogonadotropic hypogonadism caused by SOX10 gene deletion[J]. Yi Chuan, 2022, 44(12):1158-1166. |
| [6] | CHEN K, WANG H, LAI Y, et al. Kallmann syndrome due to heterozygous mutation in SOX10 coexisting with Waardenburg syndrome type Ⅱ: case report and review of literature[J]. Front Endocrinol, 2021, 11:592831. |
| [7] | WANG F, ZHAO S, XIE Y, et al. De novo SOX10 Nonsense Mutation in a Patient with Kallmann Syndrome, Deafness, Iris Hypopigmentation, and Hyperthyroidism[J]. Ann Clin Lab Sci, 2018, 48(2):248-252. |
| [8] | IZUMI Y, MUSHA I, SUZUKI E, et al. Hypogonadotropic hypogonadism in a female patient previously diagnosed as having waardenburg syndrome due to a SOX10 mutation[J]. Endocrine, 2015, 49(2):553-556. |
| [9] | SUZUKI E, I IZUMI Y, CHIBA Y, et al. Loss-of-function SOX10 mutation in a patient with Kallmann syndrome, hearing loss, and iris hypopigmentation[J]. Horm Res Paediatr, 2015, 84(3):212-216. |
| [10] | VAARALAHTI K, TOMMISKA J, TILLMANN V, et al. De novo SOX10 nonsense mutation in a patient with Kallmann syndrome and hearing loss[J]. Pediatr Res, 2014, 76(1):115-116. |
| [11] | PARRY D M, SAFYER A W, MULVIHILL J J. Waardenburg-like features with cataracts, small head size, joint abnormalities, hypogonadism, and osteosarcoma[J]. Med Genet, 1978, 15(1):66-69. |
| [12] | KELSH R N. Sorting out SOX10 functions in neural crest development[J]. Bioessays, 2006, 28 (8) :788-798. |
| [13] | PINGAULT V, ZERAD L, BERTANI-TORRES W, et al. SOX10: 20 years of phenotypic plurality and current understanding of its developmental function[J]. J Med Genet, 2022, 59 (2) :105-114. |
| [14] | 王思琪, 陈阳, 罗宽宏, 等. 一例SOX10基因缺失所致的Waardenburg综合征2型合并低促性腺激素性性腺功能减退症的诊断和基因检测分析[J]. 遗传, 2022, 44 (12) :1158-1166. |
| WANG S Q, CHEN Y, LUO K, et al. Diagnosis and gene detection analysis of a case of Waardenburg syndrome type 2 combined with hypogonadotropin hypogonadism caused by SOX10 gene deletion[J]. Heredity, 2022, 44 (12) :1158-1166. | |
| [15] | PINGAULT V, ENTE D, DASTOT-LE MOAL F, et al. Review and update of mutations causing Waardenburg syndrome[J]. Hum Mutat, 2010, 31(4):391-406. |
| [16] | AMATO L G L, MONTENEGRO L R, LERARIO A M, et al. New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism[J]. Eur J Endocrinol, 2019, 181 (2) :103-119. |
| [17] | BOEHM U, BOULOUX P M, DATTANI M T, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis,diagnosis and treatment[J]. Nat Rev Endocrinol, 2015, 11 (9) :547-564. |
| [18] | YOUNG J, XU C, PAPADAKIS G E, et al. Clinical Mana-gement of Congenital Hypogonadotropic Hypogonadism[J]. Endocr Rev, 2019, 40(2):669-710. |
/
| 〈 |
|
〉 |